Drug-Drug Interactions and Prescription Appropriateness in COVID-19 ICU Patients
Phase 4
Completed
- Conditions
- Health Condition 1: U071- COVID 19 virus identified
- Registration Number
- CTRI/2022/09/045611
- Lead Sponsor
- ESIC Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 191
Inclusion Criteria
Case record of all adult patients with proven diagnosis of SARS-CoV-2 infection (a throat swab positive for viral nucleic acid) admitted to the COVID-19 ICU during the study period and treated with at least two drugs will be considered.
Exclusion Criteria
Patients transferred to other wards from ICU or discharged/death within 24hr of admission will be excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method